Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [843]
News [2102]
Articles [21]
Editorials [1]
Conferences [129]
elearning [2]
AI model that reduces cost and time and increasing accuracy of cancer diagnosis
AI model that reduces cost and time and increasing accuracy of cancer diagnosis
Betamethasone could improve outcomes for prostate cancer radiation therapy
Betamethasone could improve outcomes for prostate cancer radiation therapy
Prompt recognition and treatment found effective for lung disease in patients who received new drug for advanced cancer
Prompt recognition and treatment found effective for lung disease in patients who received new drug for advanced...
WCLC 2022: Consolidation nivolumab and ipilimumab or nivolumab alone following concurrent chemoradiation for patients with unresectable stage III NSCLC
WCLC 2022: Consolidation nivolumab and ipilimumab or nivolumab alone following concurrent chemoradiation for...
Why do men face a higher risk of most types of cancer than women?
Why do men face a higher risk of most types of cancer than women?
WCLC 2022: IMPower010: Overall survival interim analysis of a phase III study of atezolizumab vs best supportive care in resected NSCLC
WCLC 2022: IMPower010: Overall survival interim analysis of a phase III study of atezolizumab vs best supportive...
WCLC 2022: Study of lung cancer gene panel testing demonstrates cytological specimens accurate
WCLC 2022: Study of lung cancer gene panel testing demonstrates cytological specimens accurate
WCLC 2022: Study discloses clinical-relevant intertumoural heterogeneity of NSCLC driven by MET exon 14 skipping
WCLC 2022: Study discloses clinical-relevant intertumoural heterogeneity of NSCLC driven by MET exon 14 skipping
WCLC 2022: Tumour bulk-RNA sequence identifies NSCLC patients at high risk of progression in non-complete pathological responders from NADIM trial
WCLC 2022: Tumour bulk-RNA sequence identifies NSCLC patients at high risk of progression in non-complete...
WCLC 2022: Sotorasib as a lead-in therapy with pembrolizumab or atezolizumab demonstrates durable clinical activity for advanced KRAS p.G12C NSCLC
WCLC 2022: Sotorasib as a lead-in therapy with pembrolizumab or atezolizumab demonstrates durable clinical...

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation